Celltrion Pharm

Celltrion Pharm is a South Korean pharmaceutical company and a key subsidiary of the Celltrion Group, specializing in the manufacturing and domestic distribution of chemical medicines and biosimilars. The company is well-known for its proprietary liver disease treatment, Godex, which is a leading product in the Korean market. Celltrion Pharm operates a large-scale, GMP-certified manufacturing facility in Cheongju, capable of producing various dosage forms including tablets and pre-filled syringes. It serves as the commercial hub for Celltrion's biosimilar portfolio—such as Remsima, Truxima, and Herzuma—within South Korea. Additionally, the company is expanding its portfolio into global generic markets and enhancing its R&D capabilities in small molecule drug development.